Geron

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Geron and other ETFs, options, and stocks.

About GERN

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. 

CEO
Dawn Carter Bir
CEODawn Carter Bir
Employees
229
Employees229
Headquarters
Foster City, California
HeadquartersFoster City, California
Founded
1990
Founded1990
Employees
229
Employees229

GERN Key Statistics

Market cap
837.55M
Market cap837.55M
Price-Earnings ratio
-6.26
Price-Earnings ratio-6.26
Dividend yield
Dividend yield
Average volume
10.41M
Average volume10.41M
High today
$1.43
High today$1.43
Low today
$1.30
Low today$1.30
Open price
$1.34
Open price$1.34
Volume
7.56M
Volume7.56M
52 Week high
$5.06
52 Week high$5.06
52 Week low
$1.17
52 Week low$1.17

Analyst ratings

60%

of 10 ratings
Buy
60%
Hold
30%
Sell
10%

People also own

Based on the portfolios of people who own GERN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.